Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.
NCT06267794
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Liver Fibrosis
Cirrhosis, Liver
Chronic Liver Disease
Interventions
DRUG:
Pirfenidone 1200 mg
DRUG:
Pirfenidone 1800 mg
DRUG:
Placebo
Sponsor
Jorge L Poo